DK1620113T3 - Topisk formulering af ivermectin til behandling af dermatologiske lidelser - Google Patents

Topisk formulering af ivermectin til behandling af dermatologiske lidelser

Info

Publication number: DK1620113T3
Authority: DK; Denmark
Prior art keywords: ivermectin; treatment; topical formulation; dermatological disorders; dermatological
Prior art date: 2003-04-24

Application number

DK04728811.3T

Other languages

English (en)

Inventor

Vincent Manetta

Gary R Watkins

Original Assignee

Galderma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-24

Filing date

2004-04-22

Publication date

2011-09-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33104376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1620113(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-04-22 Application filed by Galderma Sa filed Critical Galderma Sa

2004-04-22 Priority claimed from PCT/EP2004/004950 external-priority patent/WO2004093886A1/en

2011-09-12 Application granted granted Critical

2011-09-12 Publication of DK1620113T3 publication Critical patent/DK1620113T3/da

Links

AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 title 1
SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 title 1
229960002418 ivermectin Drugs 0.000 title 1
239000012049 topical pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Dispersion Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK04728811.3T 2003-04-24 2004-04-22 Topisk formulering af ivermectin til behandling af dermatologiske lidelser DK1620113T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0305048A FR2854074B1 (fr)	2003-04-24	2003-04-24	Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
US46899403P	2003-05-09	2003-05-09
PCT/EP2004/004950 WO2004093886A1 (en)	2003-04-24	2004-04-22	Topical formulation of ivermectin for the treatment of dermatological conditions

Publications (1)

Publication Number	Publication Date
DK1620113T3 true DK1620113T3 (da)	2011-09-12

Family

ID=33104376

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04728811.3T DK1620113T3 (da)	2003-04-24	2004-04-22	Topisk formulering af ivermectin til behandling af dermatologiske lidelser

Country Status (11)

Country	Link
US (6)	US8815816B2 (da)
KR (1)	KR101291824B1 (da)
CN (2)	CN103800353A (da)
AR (1)	AR044050A1 (da)
AT (1)	ATE516037T1 (da)
DK (1)	DK1620113T3 (da)
ES (1)	ES2371945T3 (da)
FR (1)	FR2854074B1 (da)
PT (1)	PT1620113E (da)
SI (1)	SI1620113T1 (da)
ZA (1)	ZA200507346B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2867684B1 (fr) *	2004-03-18	2006-05-05	Galderma Sa	Gel creme contenant de l'ivermectine
DE602005020912D1 (de)	2004-03-18	2010-06-10	Galderma Sa	Ivermectin enthaltende creme
FR2883181B1 (fr) *	2005-03-17	2007-05-18	Galderma Sa	Composition a base d'une avermectine et d'acide azelaique notamment pour le traitement de la rosacee
EP2091325B1 (en)	2006-10-12	2014-08-06	Topaz Pharmaceuticals Inc.	Shampoo-conditioner formulations comprising an avermectin for elimination of, and prophylaxis against, susceptible and treatment-resistant strains of lice
US7953614B1 (en)	2006-11-22	2011-05-31	Dr Systems, Inc.	Smart placement rules
AU2009308922B2 (en) *	2008-10-29	2016-04-14	Topaz Pharmaceuticals Inc.	Preservative system for emulsion-based therapeutic topical formulations
CN102784166B (zh) *	2012-08-01	2015-11-25	青岛绿曼生物工程有限公司	治疗家畜螨虫病的复方伊维菌素组合物及其制备方法
CN102872066B (zh)	2012-10-19	2014-07-02	厦门大学	伊维菌素及其衍生物的用途
US9233117B2 (en) *	2013-07-08	2016-01-12	Galderma S. A.	Treatment of inflammatory lesions of rosacea with ivermectin
EP3074021B1 (en)	2013-11-29	2021-05-12	Galderma SA	Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis
KR20160137592A (ko)	2014-03-28	2016-11-30	갈데르마 리써어치 앤드 디벨로프먼트	벤조일 퍼옥시드 함유 비-헹굼 화학적 무스
WO2016022066A1 (en)	2014-08-04	2016-02-11	Jerry Tan Eye Surgery Pte Ltd	Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
CN104127334A (zh) *	2014-08-19	2014-11-05	杨人源	一种杀菌除螨宠物香波
WO2016079262A1 (fr) *	2014-11-20	2016-05-26	Galderma Sa	Compositions comprenant un compose de la famille des avermectines et un compose agoniste d'au moins un des recepteurs de l'acide retinoique pour le traitement de l'acne
FR3041538B1 (fr)	2015-09-29	2018-11-30	Galderma Research & Development	Mousse chimique non rincee contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
FR3041541B1 (fr)	2015-09-29	2018-11-30	Galderma Research & Development	Mousse chimique non rincee comprenant de l'ivermectine
FR3041536B1 (fr)	2015-09-29	2018-11-30	Galderma Research & Development	Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'acne.
FR3041540B1 (fr) *	2015-09-29	2018-10-26	Galderma Research & Development	Composition nettoyante auto-moussante a rincer, contenant de l'ivermectine.
FR3041539B1 (fr)	2015-09-29	2018-10-26	Galderma Research & Development	Composition nettoyante auto-moussante contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
FR3041537B1 (fr)	2015-09-29	2018-11-30	Galderma Research & Development	Mousse chimique non rincee contenant de la brimonidine et son utilisation dans le traitement de la rosacee.
FR3041535B1 (fr)	2015-09-29	2019-01-25	Galderma Research & Development	Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'ichtyose.
CA3000898A1 (en) *	2015-10-13	2017-04-20	Galderma Sa	A process for preparing a stable emulsion comprising one or more avermectins
WO2018060870A1 (en) *	2016-09-30	2018-04-05	Aurobindo Pharma Limited	Pharmaceutical composition of ivermectin and process for preparation thereof
TR201714097A2 (tr) *	2017-09-22	2018-10-22	Assos Ilac Kimya Gida Ueruenleri Ueretim Ve Ticaret Anonim Sirketi	İvermekti̇n topi̇k formülasyon
CN119157876A (zh)	2017-12-15	2024-12-20	塔苏斯制药有限公司	用于治疗睑炎的异恶唑啉驱虫剂制剂和方法
WO2019136221A1 (en) *	2018-01-05	2019-07-11	Attillaps Holdings	Treating autoimmune disorders with chloroquine and/or hydroxychloroquine
WO2019152560A1 (en) *	2018-01-31	2019-08-08	Bio33 Degrees, Inc.	Compositions and methods for topical treatment of dermal and ocular conditions
CN108272750A (zh) *	2018-04-25	2018-07-13	菏泽学院	一种治疗动物皮肤疥癣病的软膏剂及其制备方法
KR20210019449A (ko)	2018-06-15	2021-02-22	더블유.알. 그레이스 앤드 캄파니-콘.	소포 활성제, 이의 제조 방법, 및 소포 제형
US12502377B2 (en)	2019-04-04	2025-12-23	Tarsus Pharmaceuticals, Inc.	Method of eradicating ticks that attach to humans using lotilaner formulations
WO2021247283A1 (en) *	2020-06-04	2021-12-09	Amcyte Pharma, Inc.	Delivery of aerosolized micromolar composition concentrations

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
OA06863A (fr)	1980-08-04	1983-02-28	Merck & Co Inc	Solubilisation de l'invermectine dans l'eau.
US5332577A (en) *	1988-12-27	1994-07-26	Dermamed	Transdermal administration to humans and animals
FR2725369B1 (fr) *	1994-10-07	1997-01-03	Oreal	Composition cosmetique ou dermatologique constituee d'une emulsion huile dans eau a base de globules huileux pourvus d'un enrobage cristal liquide lamellaire
US5656280A (en)	1994-12-06	1997-08-12	Helene Curtis, Inc.	Water-in-oil-in-water compositions
CA2233016C (en)	1995-09-25	2007-07-17	Ashmont Holdings Limited	Anthelmintic macrocyclic lactone compositions
FR2754452B1 (fr)	1996-10-11	2003-02-14	Oreal	Emulsion h/e a forte teneur en electrolytes et leur utilisation en dermo-cosmetique, notamment pour traiter les phenomenes d'irritation et/ou de peaux sensibles
US5952372A (en) *	1998-09-17	1999-09-14	Mcdaniel; William Robert	Method for treating rosacea using oral or topical ivermectin
US6521237B2 (en) *	1998-11-12	2003-02-18	Johnson & Johnson Consumer Companies, Inc.	Skin care composition
FR2787322B1 (fr)	1998-12-18	2002-10-18	Galderma Res & Dev	Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie
US6133310A (en) *	1999-08-26	2000-10-17	Parks; L. Dean	Method of treatment of rosacea
US6720001B2 (en) *	1999-10-18	2004-04-13	Lipocine, Inc.	Emulsion compositions for polyfunctional active ingredients
US6399652B1 (en) *	2000-06-29	2002-06-04	L. Dean Parks	Method of treating acne vulgaris using avermectin compound
US6399651B1 (en) *	2000-06-29	2002-06-04	L. Dean Parks	Method of treating dermatoses using avermectin compound
US6319945B1 (en) *	2000-06-29	2001-11-20	L. Dean Parks	Method of treatment of seborrheic dermatitis
CA2473760C (en)	2002-02-08	2008-11-04	Merck & Co., Inc.	Topical ivermectin composition
AU2003225651A1 (en)	2002-03-04	2003-09-22	Divergence, Inc.	Nematicidal fatty acid and fatty acid ester related compounds
AU2004231323C1 (en)	2003-04-24	2016-11-03	Galderma Holding SA	Topical formulation of ivermectin for the treatment of dermatological conditions
DE602005020912D1 (de)	2004-03-18	2010-06-10	Galderma Sa	Ivermectin enthaltende creme
FR2867684B1 (fr)	2004-03-18	2006-05-05	Galderma Sa	Gel creme contenant de l'ivermectine

2003
- 2003-04-24 FR FR0305048A patent/FR2854074B1/fr not_active Expired - Fee Related
2004
- 2004-04-22 ES ES04728811T patent/ES2371945T3/es not_active Expired - Lifetime
- 2004-04-22 CN CN201310731121.9A patent/CN103800353A/zh active Pending
- 2004-04-22 PT PT04728811T patent/PT1620113E/pt unknown
- 2004-04-22 CN CNA2004800109954A patent/CN1777433A/zh active Pending
- 2004-04-22 AT AT04728811T patent/ATE516037T1/de active
- 2004-04-22 KR KR1020127013727A patent/KR101291824B1/ko not_active Expired - Lifetime
- 2004-04-22 SI SI200431722T patent/SI1620113T1/sl unknown
- 2004-04-22 DK DK04728811.3T patent/DK1620113T3/da active
- 2004-04-22 AR ARP040101354A patent/AR044050A1/es not_active Application Discontinuation
2005
- 2005-09-13 ZA ZA200507346A patent/ZA200507346B/xx unknown
2013
- 2013-10-25 US US14/063,897 patent/US8815816B2/en not_active Expired - Lifetime
2014
- 2014-07-22 US US14/337,966 patent/US20140336139A1/en not_active Abandoned
2015
- 2015-07-06 US US14/792,250 patent/US20150306027A1/en not_active Abandoned
- 2015-07-06 US US14/792,201 patent/US20150306124A1/en not_active Abandoned
2017
- 2017-06-16 US US15/625,362 patent/US11033565B2/en not_active Expired - Fee Related
- 2017-06-16 US US15/625,239 patent/US20170281663A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20150306027A1 (en)	2015-10-29
CN1777433A (zh)	2006-05-24
US20140336139A1 (en)	2014-11-13
SI1620113T1 (sl)	2011-10-28
US20150306124A1 (en)	2015-10-29
ATE516037T1 (de)	2011-07-15
US20170281663A1 (en)	2017-10-05
KR20120062028A (ko)	2012-06-13
CN103800353A (zh)	2014-05-21
PT1620113E (pt)	2011-09-12
US8815816B2 (en)	2014-08-26
FR2854074B1 (fr)	2007-11-23
KR101291824B1 (ko)	2013-07-31
US20140051653A1 (en)	2014-02-20
ES2371945T3 (es)	2012-01-11
ZA200507346B (en)	2006-08-30
US20170281664A1 (en)	2017-10-05
FR2854074A1 (fr)	2004-10-29
US11033565B2 (en)	2021-06-15
AR044050A1 (es)	2005-08-24

Publication	Publication Date	Title
DK1620113T3 (da)	2011-09-12	Topisk formulering af ivermectin til behandling af dermatologiske lidelser
CY2016031I1 (el)	2017-03-15	Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων
CY2013022I1 (el)	2020-05-29	Συνθεσεις για την θεραπευτικη αγωγη γαστρεντερικων διαταραχων
ITMI20020756A1 (it)	2003-10-09	Composizioni farmaceutiche topiche per il trattamento delle dermatiti
PT1485127E (pt)	2011-09-07	Administração de agentes para o tratamento de inflamação
DK1304992T3 (da)	2009-08-10	Topisk gel-fremföringssystem til behandling af hudlidelser
DK1803718T3 (da)	2008-10-27	4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
IS8398A (is)	2006-04-05	Lyfjasamsetningar til að meðhöndla æxli
IS7099A (is)	2004-01-08	Efnasambönd til að meðhöndla bólgutruflanir
DK1480615T3 (da)	2010-07-12	Superfin formoterolformulering
NO20053077D0 (no)	2005-06-23	Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
PT1605956E (pt)	2016-03-09	Administração de capsaicinóides para o tratamento da osteoartrite
EP1653935A4 (en)	2009-05-27	INFLAMMATORY FORMULATIONS
IS7691A (is)	2005-02-09	Lyfjasamsetningar til að meðhöndla æxli
EP1727530A4 (en)	2009-10-21	TOPICAL FORMULATIONS FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS
IS8023A (is)	2005-09-13	Samsett meðferð til að meðhöndla ónæmisbólgusjúkdóma
DK1448205T3 (da)	2011-12-12	Kombinationer til behandling af immunoinflammatoriske sygdomme
DK1499730T3 (da)	2014-01-13	Immunokonjugater til behandling af tumorer
ATE476200T1 (de)	2010-08-15	Topische nepafenac-formulierungen
CY2018006I1 (el)	2018-06-27	Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
PT1513514E (pt)	2015-02-20	Formulações tópicas de hidroximatairesinol
ITMI20031311A0 (it)	2003-06-27	Formulazioni per il trattamento di disturbi artrosici
DK1487828T3 (da)	2009-02-02	Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
DE60234388D1 (de)	2009-12-24	Therapeutische lotion gegen dermatitis
DK1687297T3 (da)	2014-09-22	Triazindimerer til behandling af autoimmunsygdomme